Autres langues Centogene N.V.

Actions

CNTG

NL0014040206

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 02/07/2024			Varia. 5j.	Varia. 1 janv.
0,41 ^USD	+0,02%		+2,76%	-65,83%

20/06	Critical Path Institute et Centogene N.V. annoncent la signature d'un protocole d'accord visant à faire progresser le développement de médicaments pour les maladies lysosomales	CI
16/05	La série de données économiques à venir stimule les fonds négociés en bourse et les contrats à terme sur actions avant la cloche de jeudi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development	20/06
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development	20/06
Critical Path Institute and Centogene N.V. Announces the Signing of A Memorandum of Understanding to Advance Drug Development for Lysosomal Diseases	20/06
Centogene N : Minutes of the 2024 Annual General Meeting of Shareholders - Centogene N.V.	31/05
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting	31/05
Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday	16/05
Top Premarket Gainers	16/05
Centogene N : KSA RECEIVABLES TRANSFER AGREEMENT - Form 6-K	15/05
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights	15/05
Centogene N.V. Provides Earnings Guidance for the Year 2024	15/05
Centogene N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	15/05
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position	15/05
Centogene N : Voting Proxy AGM 2024	15/05
Centogene N : Convening Notice and Agenda (incl. explanatory notes) (AGM 2024)	15/05
Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment	14/05
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease	14/05
Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease	14/05
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients	13/05
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients	10/05
Centogene Biodatabank Grows to Incorporate Disease Insights from over 850,000 Diverse Patients	10/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Centogene N.V.

Actions

CNTG

NL0014040206

Autres langues

Filtres